Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acacia Pharma Group plc
DescriptionOromucosal formulation of an undisclosed marketed muscarinic agonist
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationXerostomia
Indication DetailsTreat xerostomia (dry mouth) in advanced cancer patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today